title: Fulvestrant 250 mg versus anastrozole for Chinese patients with advanced breast cancer: results of a multicentre, double-blind, randomised phase III trial.
authors.affiliation: Department of Medical Oncology, Cancer Hospital and Institute, Chinese Academy of Medical Sciences and Peking Union Medical College, No. 17 Panjiayuan Nanli, Chaoyang District, 100021 Beijing, China. bhxu@hotmail.com
authors.forename: Binghe
authors.initials: B
authors.lastname: Xu
authors.forename: Zefei
authors.initials: Z
authors.lastname: Jiang
authors.forename: Zhimin
authors.initials: Z
authors.lastname: Shao
authors.forename: Jiayu
authors.initials: J
authors.lastname: Wang
authors.forename: Jifeng
authors.initials: J
authors.lastname: Feng
authors.forename: Shuping
authors.initials: S
authors.lastname: Song
authors.forename: Zhendong
authors.initials: Z
authors.lastname: Chen
authors.forename: Kangsheng
authors.initials: K
authors.lastname: Gu
authors.forename: Shiying
authors.initials: S
authors.lastname: Yu
authors.forename: Yiping
authors.initials: Y
authors.lastname: Zhang
authors.forename: Chuan
authors.initials: C
authors.lastname: Wang
authors.forename: Fengchun
authors.initials: F
authors.lastname: Zhang
authors.forename: Junlan
authors.initials: J
authors.lastname: Yang